Skip to content

News

#30DaysofTeal: Day 12

#30DaysofTeal: Day 12

Show the world that #tealislove. One mother is showing her love for her daughter Sarah who was diagnosed with ovarian cancer 5 years ago at the age of 28. Sarah is now in recurrence. Sarah’s mom created a page on Teal is Love because wants the world to know the signs and symptoms of ovarian … Continued

Q&A with OCRFA Grantee Kris Wood, PhD

Q&A with OCRFA Grantee Kris Wood, PhD

Q&A with Kris Wood, PhD Duke University 2015 Liz Tilberis Award   OCRFA: Tell me about yourself. Kris Wood: I grew up in Georgetown, KY, a rural town in the central part of the state. My family lived in a house on my grandfather’s farm, which was a wonderful place to grow up– I spent … Continued

Sherry Pollex and the Ovarian Cancer National Alliance laun...

Sherry Pollex and the Ovarian Cancer National Alliance launch “The Teal Appeal” to raise ovarian cancer awareness

FOR IMMEDIATE RELEASESeptember 2, 2015 Sherry Pollex and the Ovarian Cancer National Alliance launch “The TealAppeal” to raise ovarian cancer awarenessPollex, Ovarian Cancer National Alliance, Martin Truex Jr., and Danica Patrickjoin forces during September’s National Ovarian Cancer Awareness Month, tosave more women’s lives DARLINGTON, SC — On Sunday, Sherry Pollex and the Ovarian Cancer National … Continued

Ovarian Cancer National Alliance honored for advocacy work

Ovarian Cancer National Alliance honored for advocacy work

FOR IMMEDIATE RELEASE June 15, 2015 Ovarian Cancer National Alliance honored for advocacy work OCNA called “leading advocacy organization for women impacted by ovarian cancer” WASHINGTON, DC — On Saturday, June 20, the Ovarian Cancer National Alliance (OCNA) will be honored by Facing Our Risk of Cancer Empowered (FORCE) at the 2015 Spirit of Empowerment … Continued

Teaming Up Against Ovarian Cancer

Teaming Up Against Ovarian Cancer

(9/11/15) By Alan D. D’Andrea, MD, Dana-Farber Cancer Institute and Harvard Medical School, and Elizabeth M. Swisher, MD, University of Washington September is Ovarian Cancer Awareness Month, when we scientists and advocates renew our determination to find new solutions to this devastating disease. This year we are pleased to have seen some encouraging signs. At … Continued

Ovarian Cancer Research Fund Commemorates Ovarian Cancer Aw...

Ovarian Cancer Research Fund Commemorates Ovarian Cancer Awareness Month with over $6 Million in Grants and New Initiatives

The largest private funder of ovarian cancer research awarded $6.3 million in grants while also launching new events and partnerships (September 11, 2015) –Ovarian Cancer Research Fund (OCRF), has awarded $6.3 million in grants to scientists working to cure ovarian cancer, as well as to hospitals supporting patients through OCRF’s signature Woman to Woman program. … Continued

Rachel Zoe and Husband Rodger Berman to Host OCRF's Fi...

Rachel Zoe and Husband Rodger Berman to Host OCRF's First-Ever Super Saturday Event in Las Vegas

Ovarian Cancer Research Fund’s Luxury Shopping Event to be held at Grand Canal Shoppes at The Venetian & The Palazzo and Fashion Show, September 19-20 Las Vegas, NV – Ovarian Cancer Research Fund (OCRF) will bring its popular Super Saturday shopping event to Grand Canal Shoppes at The Venetian & The Palazzo, and Fashion Show … Continued

OCRF Research Shows Heart Medication Prolongs Life in Ovari...

OCRF Research Shows Heart Medication Prolongs Life in Ovarian Cancer Patients

(August 26, 2015) Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter retrospective study.  The study was funded in part by an OCRF grant to Dr. Anil Sood at MD Anderson Cancer Center. Survival was … Continued

OCRF Research Finds Combination Immunotherapy Promising

OCRF Research Finds Combination Immunotherapy Promising

(August 19, 2015) Whereas chemotherapy kills cancer cells only while it is being administered, immunotherapy can lead to an adaptive immune response that persists long after treatment is ceased. By simple analogy, whereas aspirin provides temporary pain relief, a polio vaccine provides lifelong protection. Unfortunately, just as tumors develop resistance to conventional therapies, tumors also … Continued

New York Times Letter to the Editor

New York Times Letter to the Editor

On August 3, 2015 the New York Times published an article about the use of IP chemotherapy in the treatment of ovarian cancer. Our CEO, Calaneet Balas joined with Ovarian Cancer Research Fund CEO, Audra Moran, to write a response to the New York Times. Click the plus sign to see their Letter to the Editor.

The New York Times Publishes OCRF’s Letter to the Editor 8/...

The New York Times Publishes OCRF’s Letter to the Editor 8/12/15

(8/12/15) In response to the article “An Ovarian Cancer Treatment, Recommended Since 2006, is Found to be Underused,“ published in the Health section of The New York Times on August 3, 2015, OCRF co-wrote a Letter to the Editor along with Ovarian Cancer National Alliance, strongly encouraging physicians and treatment centers to fully consider and communicate all treatment … Continued

Ovarian Cancer Research Fund and National Sponsor QVC Expan...

Ovarian Cancer Research Fund and National Sponsor QVC Expand Woman to Woman Program

Gynecologic Cancer Patients to Receive Support in 6 New Locations WEST CHESTER, Pa (August 10, 2015) —Ovarian Cancer Research Fund (OCRF) and QVC today announced six new Woman to Woman grant recipients: Cooper University Hospital, Camden, New Jersey; Shanti Project/Kaiser Permanente, San Francisco, California; Northside Hospital Cancer Center, Atlanta, Georgia; The University of Alabama at … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.